Identification of the First COG-CDG Patient of Indian Origin.

Bobby G. Ng,Vandana Sharma,Liangwu Sun,Eva Loh,Wanjin Hong,Stacey K. H. Tay,Hudson H. Freeze
DOI: https://doi.org/10.1016/j.ymgme.2010.11.161
IF: 4.204
2010-01-01
Molecular Genetics and Metabolism
Abstract:Mutations in the Conserved Oligomeric Golgi (COG) complex give rise to type II congenital disorders of glycosylation (CDG). Thus far, mutations have been identified in 6 of the 8 COG subunits. Here we present data identifying a previously reported CDG-IIx case from Singapore as a new COG4 patient with 2 novel mutations leading to p.E233X and p.L773R; with p.E233X being a de novo mutation. As a result, COG4 protein expression was dramatically reduced, while expression of the other subunits remained unaffected. Analysis of serum N-glycans revealed deficiencies in both sialylation and galactosylation. Furthermore, patient fibroblasts have impaired O-glycosylation. Importantly, patient fibroblasts exhibited a delay in Brefeldin A (BFA) induced retrograde transport, a common characteristic seen in COG deficiencies.
What problem does this paper attempt to address?